Key result
MEX3A loss of function accelerates atherosclerosis and links to ~13% higher stroke risk.
Why the study?
Does Mex3a deletion or genetically reduced MEX3A expression increase atherosclerosis and coronary artery disease risk in mice and humans?
Does Mex3a deletion or genetically reduced MEX3A expression increase atherosclerosis and coronary artery disease risk in mice and humans?
Combined transgenic mouse models and human genetic analyses demonstrate that the RNA-binding protein Mex3a plays a vasoprotective role against atherosclerosis and coronary artery disease by preserving endothelial integrity and modulating inflammation and lipid metabolism.
Answers are grounded in this paper and cite their sources.
Supports MEX3A vasoprotection against atherosclerosis; leaves open whether targeting it modifies human cardiovascular risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Santovito et al. (2024) studied Atherosclerosis and coronary artery disease (n=1,378,170). Mex3a genetic deletion (Apoe-/-Mex3a-/-) in mice and MEX3A genetic risk/loss-of-function variants in humans vs. Apoe-/- control mice and human non-risk/wild-type MEX3A alleles was evaluated on Cerebral infarction associated with rare predicted loss-of-function MEX3A variants in UK Biobank (alongside aortic plaque formation in mice and CAD GWAS association) (OR 1.134, p=0.022). Mex3a deletion in Apoe-/- mice increased atherosclerotic plaque formation and inflammation, while human MEX3A loss-of-function variants increased cerebral infarction risk.
Synapse has enriched 10 related papers. Consider them for comparative context: